Chemotherapy liver injury

Surgery

Volumn 147, Issue 2, 2010, Pages 195-196

  Anderson, Christopher D ^a   Chari, Ravi S ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTENNIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRINOTECAN; OXALIPLATIN;

CANCER CHEMOTHERAPY; COLORECTAL CARCINOMA; EDITORIAL; FATTY LIVER; GENDER; HUMAN; LIVER HYPERTROPHY; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; LIVER SINUSOID; LIVER TOXICITY; MULTIPLE CYCLE TREATMENT; OBESITY; PRIORITY JOURNAL; STEATITIS;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; HUMANS; LIVER; LIVER NEOPLASMS; NEOADJUVANT THERAPY;

EID: 74049153677     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2009.09.030     Document Type: Editorial

References (11)

1. Chun Y.S., Laurent A., Maru D., and Vauthey J.N. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 10 (2009) 278-286
2. Khan A.Z., Morris-Stiff G., and Makuuchi M. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases. J Hepatobiliary Pancreat Surg 16 (2009) 137-144
3. Kandutsch S., Klinger M., Hacker S., Wrba F., Gruenberger B., and Gruenberger T. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases. Eur J Surg Oncol 34 (2008) 1231-1236
4. Nakano H., Oussoultzoglou E., Rosso E., Casnedi S., Chenard-Neu M.P., Dufour P., et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247 (2008) 118-124
5. Vauthey J.N., Pawlik T.M., Ribero D., Wu T.T., Zorzi D., Hoff P.M., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072
6. Rubbia-Brandt L., Audard V., Sartoretti P., Roth A.D., Brezault C., Le Charpentier M., et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15 (2004) 460-466
7. Brouquet A., Benoist S., Julie C., Brezault C., Le Charpentier M., Dousset B., et al. Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 145 (2009) 362-371
8. Covey A.M., Brown K.T., Jarnagin W.R., Brody L.A., Schwartz L., Tuorto S., et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247 (2008) 451-455
9. Belghiti J. Arguments for a selective approach of preoperative portal vein embolization before major hepatic resection. J Hepatobiliary Pancreat Surg 11 (2004) 21-24
10. Kopetz S., and Vauthey J.N. Perioperative chemotherapy for resectable hepatic metastases. Lancet 371 (2008) 963-965
11. Pawlik T.M., Olino K., Gleisner A.L., Torbenson M., Schulick R., and Choti M.A. Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11 (2007) 860-868